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Ovarian cancer is the most deadly gynecologic malignancy in women. A particular subset 
of this disease, epithelial ovarian cancer (EOC), is responsible for over 70% of all 
diagnosed ovarian cancer cases, yet the mechanisms governing disease progression are 
poorly understood. One of the unique hallmarks of EOC metastasis lies in the process of 
spheroid formation, whereby tumour cells aggregate into larger 3D structures. These 
EOC spheroids have been shown to be metabolically dormant, while concurrently up-
regulating autophagy (cellular waste recycling) processes. This particular change in 
cellular activity seems to promote increased EOC chemotherapy resistance. My project 
examines the role of AMP-activated protein kinase (AMPK), a cellular metabolic sensor, 
and its role in regulating autophagy induction in EOC spheroids.  
 
Methods:  
Following AMPK knockdown using siRNA, protein markers for both AMPK and 
autophagy signalling will be assessed through immunoblotting, immunocytochemistry 
and fluorescence microscopy. Additional experiments will examine cellular viability of 
AMPK deficient EOC spheroids compared to their wild type counterparts following 
chemotherapy treatment.  
 
Expected Results: 
I expect that reducing the levels of cellular AMPK will disrupt autophagy induction, 
thereby sensitizing EOC spheroids to chemotherapy treatment. 
 
Discussion & Conclusion: 
Uncovering the mechanisms that govern autophagy induction in EOC spheroids will 
allow researchers to target a vulnerability in EOC to further develop therapeutics against 
this type of malignancy. 
 
Interdisciplinary Reflection:  
My research bridges molecular biology with clinical oncology, allowing for a more 
detailed understanding of the pathology of this deadly disease.  
